Cargando…

Irritability in Huntington’s Disease

Huntington’s disease (HD) is a heritable and fatal neurodegenerative disease characterized by a triad of motor, cognitive and neuropsychiatric symptoms. A common and particularly detrimental neuropsychiatric alteration in HD gene carriers is irritability, which frequently manifests as abrupt and unp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karagas, Nicholas E., Rocha, Natalia Pessoa, Stimming, Erin Furr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369067/ https://www.ncbi.nlm.nih.gov/pubmed/32417789 http://dx.doi.org/10.3233/JHD-200397

Ejemplares similares

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Promises and pitfalls of immune-based strategies for Huntington's disease
por: Colpo, Gabriela Delevati, et al.
Publicado: (2017)

Revisiting the neuropsychiatry of Huntington's disease
por: Teixeira, Antonio Lucio, et al.
Publicado: (2016)

Gene Expression Profiling in Huntington’s Disease: Does Comorbidity with Depressive Symptoms Matter?
por: Colpo, Gabriela Delevati, et al.
Publicado: (2020)

Neuroimmunology of Huntington's Disease: Revisiting Evidence from Human Studies
por: Rocha, Natalia P., et al.
Publicado: (2016)

Peripheral Levels of Renin-Angiotensin System Components Are Associated With Cognitive Performance in Huntington’s Disease
por: Rocha, Natalia P., et al.
Publicado: (2020)

The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
por: Rocha, Natalia P., et al.
Publicado: (2018)

Microglia Activation in Basal Ganglia Is a Late Event in Huntington Disease Pathophysiology
por: Rocha, Natalia P., et al.
Publicado: (2021)

Treatment of Irritability in Huntington’s Disease
por: van Duijn, Erik
Publicado: (2010)

Renin-Angiotensin System in Huntington′s Disease: Evidence from Animal Models and Human Patients
por: Kangussu, Lucas M., et al.
Publicado: (2022)

Irritability in pre-clinical Huntington's disease
por: Klöppel, Stefan, et al.
Publicado: (2010)

HAP40 is a conserved central regulator of Huntingtin and a potential modulator of Huntington’s disease pathogenesis
por: Xu, Shiyu, et al.
Publicado: (2022)

An International Survey-based Algorithm for the Pharmacologic Treatment of Irritability in Huntington's Disease
por: Groves, Mark, et al.
Publicado: (2011)

Excessive response to provocation rather than disinhibition mediates irritable behaviour in Huntington’s disease
por: McLauchlan, Duncan James, et al.
Publicado: (2022)

Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy
por: Moruno Manchon, Jose Felix, et al.
Publicado: (2015)

What Is the Evidence for Using Anti-Epileptic Drugs to Treat Agitation and Irritability in Huntington's Disease?
por: Leong, Kok Keong, et al.
Publicado: (2022)

Assessing Behavioural Manifestations Prior to Clinical Diagnosis of Huntington Disease: "Anger and Irritability" and "Obsessions and Compulsions"
por: Vaccarino, Anthony L, et al.
Publicado: (2011)

Antidopaminergic treatment is associated with reduced chorea and irritability but impaired cognition in Huntington’s disease (Enroll-HD)
por: Harris, Kate L, et al.
Publicado: (2020)

Huntington disease: Advances in the understanding of its mechanisms()
por: Gatto, Emilia M., et al.
Publicado: (2020)

Sleep Dysfunction in Huntington’s Disease: Impacts of Current Medications and Prospects for Treatment
por: Owen, Natalia E., et al.
Publicado: (2023)

Huntington Disease in Asia
por: Xu, Miao, et al.
Publicado: (2015)

Huntington's disease: the case for genetic modifiers
por: Gusella, James F, et al.
Publicado: (2009)

The Neurodevelopmental Hypothesis of Huntington’s Disease
por: van der Plas, Ellen, et al.
Publicado: (2020)

Therapeutic Advances for Huntington’s Disease
por: Kumar, Ashok, et al.
Publicado: (2020)

Therapeutic Strategies in Huntington's Disease
por: Kanazawa, Ichiro
Publicado: (2006)

Neurodegenerative processes in Huntington's disease
por: Bano, D, et al.
Publicado: (2011)

Neuropsychiatric Burden in Huntington’s Disease
por: Paoli, Ricardo Augusto, et al.
Publicado: (2017)

PET Imaging in Huntington’s Disease
por: Roussakis, Andreas-Antonios, et al.
Publicado: (2015)

DNA Methylation in Huntington’s Disease
por: Zsindely, Nóra, et al.
Publicado: (2021)

Pridopidine: Overview of Pharmacology and Rationale for its Use in Huntington’s Disease
por: Waters, Susanna, et al.
Publicado: (2018)

Huntington's Disease: An Immune Perspective
por: Nayak, Annapurna, et al.
Publicado: (2011)

Plants and phytochemicals for Huntington's disease
por: Choudhary, Sunayna, et al.
Publicado: (2013)

SUMO-modifying Huntington’s disease
por: Soares, Ericks S., et al.
Publicado: (2022)

Huntington's disease: a clinical review
por: Roos, Raymund AC
Publicado: (2010)

Therapeutic Advances in the Management of Huntington’s Disease
por: Abdulrahman, Ganiy Opeyemi
Publicado: (2011)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

The Many Facets of Unawareness in Huntington Disease
por: McCusker, Elizabeth, et al.
Publicado: (2014)

New Avenues for the Treatment of Huntington’s Disease
por: Kim, Amy, et al.
Publicado: (2021)

Emerging Roles of Exosomes in Huntington’s Disease
por: Ananbeh, Hanadi, et al.
Publicado: (2021)

Molecular Pathophysiological Mechanisms in Huntington’s Disease
por: Jurcau, Anamaria
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_91np81fbu1u0snschnd1p2ll2s